MGB Biopharma completes funding round
MGB Biopharma, a biopharmaceutical company developing a new class of anti-infectives to address antibiotic resistance, has completed its latest funding round. which was supported by new and existing investors, led by Archangel Investors and including Scottish Investment Bank (the investment arm of Scottish Enterprise, Scotland’s national economic development agency), Barwell